{
    "organizations": [],
    "uuid": "f1c999baae9a2aeb51f968c5d098e13d65edff45",
    "author": "",
    "url": "https://www.reuters.com/article/brief-valirx-announces-us-patent-grant-f/brief-valirx-announces-us-patent-grant-for-therapeutic-compound-val201-idUSFWN1R201C",
    "ord_in_thread": 0,
    "title": "BRIEF-Valirx Announces US Patent Grant for Therapeutic Compound, VAL201",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 20, 2018 / 7:24 AM / Updated 44 minutes ago BRIEF-Valirx Announces US Patent Grant for Therapeutic Compound, VAL201 Reuters Staff 1 Min Read March 20 (Reuters) - Valirx Plc: * USA PATENT AND TRADEMARK OFFICE GRANTED US PATENT APPLICATION COVERING VALIRX’S LEAD THERAPEUTIC COMPOUND​ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)",
    "published": "2018-03-20T09:20:00.000+02:00",
    "crawled": "2018-03-20T10:06:06.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "updated",
        "minute",
        "ago",
        "announces",
        "u",
        "patent",
        "grant",
        "therapeutic",
        "compound",
        "val201",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "valirx",
        "plc",
        "usa",
        "patent",
        "trademark",
        "office",
        "granted",
        "u",
        "patent",
        "application",
        "covering",
        "valirx",
        "lead",
        "therapeutic",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}